Summary
A Phase III double-blind, placebo-controlled study to assess the efficacy, safety, and tolerability of Drug A in patients with moderate to severe chronic back pain.
Register to download
Succeeding with a Risk-Based Approach
You may also be interested in:
Case Study
Overcoming Difficult Recruitment Challenges to Meet Vaccine Study Enrollment Goals
A randomized, observer-blind, placebo-controlled, multi-center, multi-national, Phase III trial evaluating the efficacy, immunogenicity, and safety…
View Resource
page
Wearables and Virtual Trials
At PRA, we’re elevating clinical trial design to work for patients in today’s modern world. By leveraging our data, expertise, and technologies, we…
Read More
Fact Sheet
Vaccine Solutions
PRA’s Vaccine Solutions group understands the unique challenges and characteristics of vaccine development. Right from the start, our experts will…
View Resource
View all related content and resources for Study Design
Explore Insights